Medicare Enrolled

Dr. Christopher Sherman, M.D.

Urology Physician · Largo, FL
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
1775 E BAY DR, Largo, FL 33771
7274411508
In practice since 2010 (16 years)
NPI: 1851616635 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Sherman from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Sherman? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Sherman

Dr. Christopher Sherman is an urology physician in Largo, FL, with 16 years in practice. Based on federal Medicare data, Dr. Sherman performed 9,204 Medicare services across 3,378 unique beneficiaries.

Between the years covered by Open Payments, Dr. Sherman received a total of $12,303 from 63 pharmaceutical and/or device companies across 462 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Sherman is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 16 years in practice▲ Top 12% volume in FL$ $12,303 industry payments

Medicare Practice Summary

Medicare Utilization ↗
9,204
Medicare services
Top 12% in FL for urology physician
3,378
Unique beneficiaries
$43
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~575 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Denosumab injection (Prolia/Xgeva)4,380$18$42
Automated urinalysis1,122$2$5
Office visit, established patient (30-39 min)804$93$321
Office visit, established patient (20-29 min)648$65$227
Leuprolide acetate (for depot suspension), 7.5 mg210$137$385
Limited ultrasound scan behind abdominal cavity191$40$117
Chronic care management, first 20 min/month189$49$159
Diagnostic exam of bladder and urethra using an endoscope163$182$603
New patient office visit (45-59 min)157$121$422
Blood draw (venipuncture)140$6$6
Hospital follow-up visit, low complexity139$40$97
Bladder ultrasound after voiding104$8$26
Hospital follow-up visit, moderate complexity101$64$179
Drug injection, under skin or into muscle82$11$35
Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings72$28$163
Electronic assessment of bladder emptying54$6$36
Complex measurement of pressure of urine flow in bladder with urethra pressure and voiding pressure studies53$296$976
Insertion of device into abdomen with pressure and urine flow rate study53$150$483
Insertion of lower leg neurostimulator electrode53$91$302
Complete ultrasound scan of pelvis46$74$210
Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle42$26$81
Electronic analysis of implanted neurostimulator generator with complex spinal cord or peripheral nerve stimulator programming41$43$143
Insertion of stent in ureter using an endoscope33$136$397
Exam with injections of chemical for destruction of bladder using an endoscope30$137$435
Initial hospital admission, moderate complexity30$105$341
Initial hospital admission, high complexity28$140$498
Telephone medical discussion with physician, 11-20 minutes27$46$189
Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes26$68$256
Simple insertion of temporary bladder tube25$45$157
New patient office visit (30-44 min)23$85$283
Injection, garamycin, gentamicin, up to 80 mg22$2$3
Insertion of peripheral or gastric neurostimulator generator17$77$413
Crushing of stone of ureter with insertion of stent using an endoscope16$339$1,062
Insertion of sacral nerve neurostimulator electrode array15$872$1,907
Insertion of tube into ureter using an endoscope through bladder area14$46$337
Other procedure on male genital system14$137$1,000
Imaging guidance for procedure, 60 minutes or less14$13$36
Irrigation and removal of multiple blood clots from bladder and urethra using an endoscope13$226$734
Removal of prostate gland using an electrocautery knife through urethra with control of bleeding using an endoscope13$571$1,869
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.5% high complexity
53.4% medium
46.1% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$12,303
Total received (2018-2024)
Avg $1,758/year across 7 years
Top 17% in FL for urology physician
63
Companies
462
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$12,278 (99.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$25 (0.2%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,644
2023
$2,876
2022
$2,997
2021
$885
2020
$688
2019
$1,700
2018
$1,513

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Axonics, Inc.
$3,395
Coloplast Corp
$965
Astellas Pharma US Inc
$800
Myriad Genetic Laboratories, Inc.
$515
PFIZER INC.
$506
Dendreon Pharmaceuticals LLC
$499
Janssen Biotech, Inc.
$470
Amgen Inc.
$389
Sumitomo Pharma America, Inc.
$368
Ferring Pharmaceuticals Inc.
$277
Endo Pharmaceuticals Inc.
$275
ABBVIE INC.
$242
Boston Scientific Corporation
$235
Merck Sharp & Dohme LLC
$214
AstraZeneca Pharmaceuticals LP
$200
Bayer HealthCare Pharmaceuticals Inc.
$161
PROCEPT BioRobotics Corporation
$158
Blue Earth Diagnostics Limited
$157
Avadel Specialty Pharmaceuticals, LLC
$155
AbbVie Inc.
$141
Novartis Pharmaceuticals Corporation
$133
MEDIVATION FIELD SOLUTIONS LLC
$115
BOSTON SCIENTIFIC CORPORATION
$114
Janssen Scientific Affairs, LLC
$110
Tolmar, Inc.
$102
UroGen Pharma, Inc.
$99
SN Holdings, LLC
$97
TOLMAR Pharmaceuticals, Inc.
$91
Bayer Healthcare Pharmaceuticals Inc.
$86
Myovant Sciences Inc.
$80
PROGENICS PHARMACEUTICALS, INC.
$73
Progenics Pharmaceuticals, Inc.
$70
Laborie Medical Technologies Corp.
$68
Telix Pharmaceuticals
$63
UROVANT SCIENCES INC
$63
Clarus Therapeutics Inc.
$54
ACCORD HEALTHCARE, INC.
$51
180 Medical, Inc.
$50
Zyla Life Sciences
$48
UROGEN PHARMA, INC.
$43
AbbVie, Inc.
$41
Axonics Modulation Technologies, Inc.
$39
Endo USA, Inc.
$36
BLUEWIND MEDICAL
$36
SUN PHARMACEUTICAL INDUSTRIES INC.
$34
Teleflex LLC
$32
Medtronic USA, Inc.
$30
Allergan, Inc.
$29
C. R. BARD, INC. & SUBSIDIARIES
$28
ROCHESTER MEDICAL CORPORATION
$27
Foundation Medicine, Inc.
$27
Rochester Medical Corporation
$25
COLOPLAST CORP
$24
Medtronic, Inc.
$20
Calyxo, Inc.
$20
Sun Pharmaceutical Industries Inc.
$19
DENTSPLY IH Inc.
$19
Allergan Inc.
$19
Olympus America Inc.
$16
Shionogi Inc
$14
NeoTract Inc.
$13
Zyla Life Sciences, Inc.
$11
Ambu Inc.
$10
Top 3 companies account for 41.9% of total payments
Associated products mentioned in payments ›
ADSTILADRIN · AMS 700 CXR RTE KIT · AQUABEAM ROBOTIC SYSTEM · AQUABEAM SYSTEM · AVEED · Axonics · Axonics r-SNM System · Axumin · BOTOX · BRAC CDx · Bulkamid · CAMCEVI · CVAC ASPIRATION SYSTEM · ELIGARD · ERLEADA · Erleada · FIRMAGON · Fetroja · GEMTESA · GENERAL KIDNEY STONE DISEASE · GENERAL - KIDNEY STONE DISEASE · GENERAL BPH · GENERAL KIDNEY STONE DISEASE · ILLUCCIX · INTERSTIM · JATENZO · JELMYTO · KEYTRUDA · LUPRON DEPOT · LYNPARZA · LoFric · Lupron · Lupron Depot · MYRBETRIQ · Myrbetriq · NOCDURNA · Noctiva · Nubeqa · ORGOVYX · PLUVICTO · POSLUMA · PROLARIS · PROVENGE · PYLARIFY · Prolaris · Prolia · REVI · REZUM · SONICISION · SPEEDICATH · SPRIX · SpaceOAR VUE System - 10mL · SpeediCath · TITAN · TOROSA · TOVIAZ · UROLIFT · UroLift · VERIFY · XGEVA · XIAFLEX · XTANDI · Xofigo · Xtandi · YONSA · iTIND System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $134 per 100 Medicare services performed
Looking for a urology physician in Largo?
Compare urology physicians in the Largo area by procedure volume, costs, and industry payment transparency.
Browse urology physicians nearby

Geographic Context

Urology Physicians within 10 mi
102
Per 100K population
10.6
County median income
$70,293
Nearest hospital
WINDMOOR HEALTHCARE OF CLEARWATER
2.4 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Sherman is a clinical cardiology specialist, with above-average Medicare volume (top 12% in FL), and high industry engagement (low-engagement, top 17%), with 16 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Sherman experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Sherman performed 4,380 denosumab injection (prolia/xgeva) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Sherman receive payments from pharmaceutical companies?
Yes. Dr. Sherman received a total of $12,303 from 63 companies across 462 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Sherman's costs compare to other urology physicians in Largo?
Dr. Sherman's average Medicare payment per service is $43. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Sherman) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →